Anaptysbio (ANAB) Non-cash Items (2024 - 2026)
Anaptysbio (ANAB) reported Non-cash Items of $3.9 million for Q1 2026, down 97.82% quarter-over-quarter from $180.4 million in Q4 2025.
Anaptysbio (ANAB) Non-cash Items (2024 - 2026) Analysis & Trends
Anaptysbio has reported Non-cash Items for 3 years, with the latest figure at $3.9 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (changed N/A YoY), and the FY2025 full-year result was $180.4 million, up 33689.14% from the prior year.
- Non-cash Items for Q1 2026 stood at $3.9 million, down from $180.4 million in the prior quarter.
- The five-year high for Non-cash Items was $180.4 million in Q4 2025, with the low at $534000.0 in Q4 2024.
- Historically, Non-cash Items has averaged $61.6 million across 3 years, with a median of $3.9 million in 2026.
- The largest YoY upside for Non-cash Items was 33689.14% in 2025 against a maximum downside of 33689.14% in 2025.
- Anaptysbio's Non-cash Items stood at $534000.0 in 2024, then soared by 33689.14% to $180.4 million in 2025, then slumped by 97.82% to $3.9 million in 2026.
- The last three Non-cash Items figures came in at $3.9 million (Q1 2026), $180.4 million (Q4 2025), and $534000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 180.43 Mn |
| Dec 31, 2025 | 180.43 Mn |
| Dec 31, 2024 | 534,000.00 |
| Dec 31, 2024 | 534,000.00 |